1. Neuropathic phenotypes of type 1 diabetes are related to different signatures of magnetic resonance spectroscopy-assessed brain metabolites.
- Author
-
Hansen TM, Croosu SS, Røikjer J, Mørch CD, Ejskjaer N, and Frøkjær JB
- Subjects
- Humans, Female, Male, Adult, Middle Aged, Aspartic Acid analogs & derivatives, Diabetes Mellitus, Type 1 metabolism, Brain metabolism, Brain diagnostic imaging, Phenotype, Diabetic Neuropathies metabolism, Diabetic Neuropathies diagnostic imaging, Magnetic Resonance Spectroscopy methods
- Abstract
Objectives: The study aimed to investigate brain metabolites in type 1 diabetes and the associations with disease characteristics. We explored the metabolic profiles predicting different neuropathic phenotypes using multiple linear regression analyses., Methods: We compared brain metabolites in 55 adults with type 1 diabetes (including painful diabetic peripheral neuropathy (DPN), painless DPN, without DPN) with 20 healthy controls. Proton magnetic resonance spectroscopy measurements (N-acetylaspartate (NAA), glutamate (glu), myo-inositol (mI), and glycerophosphocholine (GPC) were obtained in ratios to creatine (cre)) from the parietal region, anterior cingulate cortex and thalamus., Results: The overall diabetes group revealed decreased parietal NAA/cre compared to healthy controls (1.41 ± 0.12 vs. 1.55 ± 0.13,p < 0.001) and increased mI/cre (parietal: 0.62 ± 0.08 vs. 0.57 ± 0.07,p = 0.025, cingulate: 0.65 ± 0.08 vs. 0.60 ± 0.08,p = 0.033). Reduced NAA/cre was associated with more severe DPN (all p ≤ 0.04) whereas increased mI/cre was associated with higher hemoglobin A
1c (HbA1c ) (p = 0.02). Diabetes was predicted from decreased parietal NAA/cre, increased parietal ml/cre, and decreased thalamic glu/cre. DPN was predicted from decreased parietal NAA/cre and increased GPC/cre. Painful DPN was predicted from increased parietal GPC/cre and thalamic glu/cre., Conclusions: Specific metabolic brain profiles were linked to the different phenotypes of diabetes, DPN and painful DPN., Significance: Assessment of metabolic profiles could be relevant for detailed understanding of central neuropathy in diabetes., Competing Interests: Declarations of interest None., (Copyright © 2024 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF